Understanding a gene linked to inherited eye diseases
Official title: Illuminating the function of CACNA2D4 in inherited retinal dystrophies
Funded at University of Texas at Austin · NIH-10896666 · Data updated 2026-11-12
This study is looking at a gene called CACNA2D4 to better understand how it affects eye conditions like cone dystrophies and retinitis pigmentosa, with the hope of finding new treatments to help people with these inherited retinal disorders.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project start | March 21, 2024 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $158,750 |
| NIH project number | 1R03TR005086-01 |
| Project ID | NIH-10896666 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with inherited retinal dystrophies, particularly those linked to the CACNA2D4 gene.
✕Less likely to help
Patients with retinal disorders not associated with the CACNA2D4 gene may not benefit from this research.
What this research studies
This research investigates the CACNA2D4 gene, which is associated with inherited retinal disorders like cone dystrophies and retinitis pigmentosa. By exploring how the a2d-4 protein functions in photoreceptors, the researchers aim to uncover the mechanisms that lead to these eye diseases. They will employ advanced techniques such as electrophysiology and optical imaging to study the gene's role in neurotransmitter release and its structural relationships. The findings could pave the way for new therapies targeting these conditions.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for patients suffering from inherited retinal disorders.
How similar studies have gone: While the specific focus on CACNA2D4 is novel, similar research on ion channel proteins has shown promise in understanding and treating retinal disorders.
Where this research is happening
-
University of Texas at Austin
Austin, United States Active
Researchers
- Principal investigator: Lee, Amy — University of Texas at Austin
- Study coordinator: Lee, Amy
Related research
Other NIH-funded projects on the same topics.
-
Translating new nerve grafts to clinical use
Aims to bring advanced nerve graft technology that uses PEG-fusion and localized immunosuppression to patients with nerve gaps.
-
GABA-A receptor gating mechanisms and how drugs affect them
Researchers are studying how GABA-A receptor gates work and how medicines can modulate them to help people with epilepsy, Alzheimer's-related symptoms, and other brain disorders.
-
Nanoparticles that calm inflammation after artery procedures
A new nanoparticle inspired by dying cells is being tested to reduce inflammation after artery procedures and help PAD patients heal better.
-
Silent speech interface using a wearable tongue tracker to help people after laryngectomy communicate
A wearable system with tongue sensors and intraoral components aims to let people without a vocal cord use natural-sounding speech in daily life.
-
Understanding and reversing abnormal brain activity in Alzheimer's disease
Aims to understand how unusual brain activity contributes to Alzheimer’s and test ways to reverse it to help people with the condition.
-
CFDE Cloud Workspace to help researchers share and analyze data
A cloud-based workspace will let a wide range of researchers import, integrate, and analyze data from CFDE and other sources using familiar tools and workflows.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.